Context Therapeutics Inc. — Form D

Context Therapeutics Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-16. The offering totals $100.0M, of which $100.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2024-05-16
• Form: D
• Accession: 0001842952-24-000037
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $100.0M
• Amount sold: $100.0M
• Remaining: $5K
• Investors: 26
• Date of first sale: 2024-05-06
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-513547

Issuer

• Name: Context Therapeutics Inc.
• CIK: 0001842952
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 2001 MARKET STREET, PHILADELPHIA, PA, 19103
• Phone: 267-225-7416

Officers, directors & promoters (8)

More

• CIK 1842952 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search